Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. Financials
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 30 50749 31877 06148 16348 163-
Enterprise Value (EV)1 30 07948 25476 42346 35845 68744 075
P/E ratio 26,8x38,3x48,0x25,6x21,1x17,5x
Yield 1,22%1,14%0,71%1,42%1,71%1,94%
Capitalization / Revenue 9,48x13,3x15,3x8,29x6,83x5,88x
EV / Revenue 9,35x13,0x15,2x7,98x6,48x5,38x
EV / EBITDA 19,6x27,2x32,7x17,4x14,2x11,3x
Price to Book 5,52x7,54x10,1x5,36x4,51x3,73x
Nbr of stocks (in thousands) 1 813 6711 823 9771 824 3671 824 3671 824 367-
Reference price (CNY) 16,827,042,226,426,426,4
Announcement Date 02/25/201902/28/202003/10/2021---
1 CNY in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 3 2173 7005 0235 8127 0538 191
EBITDA1 1 5311 7762 3372 6703 2153 916
Operating profit (EBIT)1 1 3911 6152 1372 4493 0033 670
Operating Margin 43,3%43,7%42,5%42,1%42,6%44,8%
Pre-Tax Profit (EBT)1 1 3901 6102 1342 4833 0633 756
Net income1 1 1401 2831 6041 8752 2762 738
Net margin 35,4%34,7%31,9%32,3%32,3%33,4%
EPS2 0,630,710,881,031,251,51
Dividend per Share2 0,210,310,300,380,450,51
Announcement Date 02/25/201902/28/202003/10/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 6236652 0722 5321 0241 283
EBITDA ------
Operating profit (EBIT)1 3052298561 075286305
Operating Margin 49,0%34,4%41,3%42,5%27,9%23,8%
Pre-Tax Profit (EBT) 303228----
Net income 253204----
Net margin 40,6%30,7%----
EPS2 0,140,110,330,460,140,16
Dividend per Share ------
Announcement Date 04/29/202108/29/202110/29/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 4281 0646381 8052 4764 088
Leverage (Debt / EBITDA) -0,28x-0,60x-0,27x-0,68x-0,77x-1,04x
Free Cash Flow1 1 1101 0907042 0742 2403 314
ROE (Net Profit / Equities) 22,4%19,9%23,0%21,4%22,2%22,2%
Shareholders' equity1 5 0966 4536 9858 74310 25912 361
ROA (Net Profit / Asset) 19,5%18,2%18,2%16,7%18,3%19,7%
Assets1 5 8567 0388 81211 26112 43613 923
Book Value Per Share2 3,053,594,174,925,857,07
Cash Flow per Share2 0,710,750,731,191,021,58
Capex1 183273621327319260
Capex / Sales 5,69%7,37%12,4%5,62%4,52%3,17%
Announcement Date 02/25/201902/28/202003/10/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Key data
Capitalization (CNY) 48 163 281 566
Capitalization (USD) 7 597 930 520
Net sales (CNY) 5 023 206 260
Net sales (USD) 793 254 686
Number of employees 2 887
Sales / Employee (CNY) 1 739 940
Sales / Employee (USD) 274 768
Free-Float 52,7%
Free-Float capitalization (CNY) 25 360 744 833
Free-Float capitalization (USD) 4 000 748 514
Avg. Exchange 20 sessions (CNY) 669 856 361
Avg. Exchange 20 sessions (USD) 105 782 377
Average Daily Capital Traded 1,39%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA